UCB0022 / UCB 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
UCB0022 / UCB
ATLANTIS, NCT06055985: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease

Recruiting
2
189
US
Placebo, UCB0022
UCB Biopharma SRL
Parkinson Disease
03/25
04/25
NCT04867642: A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease

Completed
1
100
Europe
UCB0022, Placebo, PBO
UCB Biopharma SRL
Healthy Study Participants, Parkinson's Disease
02/23
02/23

Download Options